Extending the availability of its endovascular innovations into another major world market, Medtronic, Inc. (NYSE: MDT), today announced regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the Talent™ Thoracic Stent Graft, a lifesaving technology that allows more patients to benefit from a minimally-invasive treatment for certain types of aneurysms of the descending thoracic aorta. Continue reading ...
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment